Ensysce Biosciences Announces Partnership With Specialty Drug Manufacturer

TipRanksDec 4 08:20 ET

Express News | Ensysce Biosciences Initiates PARtnership With A Drug Manufacturer For The Development And Commercial Launch Of PF614 And PF614-MPAR, Including A $10M Commitment From The Drug Manufacturer

BenzingaDec 4 08:17 ET

Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

BenzingaDec 4 05:11 ET

Ensysce Biosciences Plans To Implement 1-For-15 Reverse Split Of Its Common Stock, Effective December 6, 2024

BenzingaDec 3 16:19 ET

Express News | Ensysce Biosciences Inc: Announces 1-for-15 Reverse Stock Split

ReutersDec 3 16:17 ET

Express News | Ensysce Biosciences Treats First Group Of Subjects In PF614-MPAR-102 Study

BenzingaNov 26 08:11 ET